Clinical Trial Update: Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology [Phase 3]

View source ↗

Summary

A Phase 3 trial compares tadalafil versus placebo to improve hemodynamics and end-organ function in Fontan physiology. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fontan Physiology
• Single-ventricle Congenital Heart Disease

Drugs mentioned

• Cialis (tadalafil)

Snippet

Sponsor: Mayo Clinic | Conditions: Fontan Palliation | Phase 3 | Status: RECRUITING